相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer
Elizabeth Iorns et al.
CANCER CELL (2008)
Overcoming endocrine resistance in breast cancer-are signal transduction inhibitors the answer?
Philippe L. Bedard et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Minimizing the risk of reporting false positives in large-scale RNAi screens
Christophe J. Echeverri et al.
NATURE METHODS (2006)
Identification and characterization of the CDK12/cyclin L1 complex involved in alternative splicing regulation
HH Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Adaptive hypersensitivity to estrogen: Mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment
RJ Santen et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Mechanisms of tamoxifen resistance: Increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer
J Shou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity
M Kasten et al.
ONCOGENE (2001)
Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells
S Cariou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
